Zdrowie i gospodarka · 06/11/2014
FDA Releases Draft Guidance on Bioequivalence Recommendations for Concerta Extended-Release Tablets
The FDA has made available a draft guidance for industry that provides specific recommendations for designing bioequivalence studies to support abbreviated new drug applications referencing Concerta, a medication used to treat attention deficit hyperactivity disorder (ADHD).